Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment

R Liu, C Luo, Z Pang, J Zhang, S Ruan, M Wu… - Chinese chemical …, 2023 - Elsevier
R Liu, C Luo, Z Pang, J Zhang, S Ruan, M Wu, L Wang, T Sun, N Li, L Han, J Shi, Y Huang
Chinese chemical letters, 2023Elsevier
Decades have passed since the first nanoparticles-base medicine was approved for human
cancer treatment, and the research and development of nanoparticles for drug delivery are
always undergoing. Nowadays, the significant advances complicate nanoparticles'
branches, including liposomes, solid lipid nanoparticles, inorganic nanoparticles, micelles,
nanovaccines and nano-antibodies, etc. These nanoparticles show numerous capabilities in
treatment and diagnosis of stubborn diseases like cancer and neurodegenerative diseases …
Abstract
Decades have passed since the first nanoparticles-base medicine was approved for human cancer treatment, and the research and development of nanoparticles for drug delivery are always undergoing. Nowadays, the significant advances complicate nanoparticles’ branches, including liposomes, solid lipid nanoparticles, inorganic nanoparticles, micelles, nanovaccines and nano-antibodies, etc. These nanoparticles show numerous capabilities in treatment and diagnosis of stubborn diseases like cancer and neurodegenerative diseases, emerging as novel drug carriers or therapeutic agents in future. In this review, the complicated branches of nanoparticles are classified and summarized, with their property and functions concluded. Besides, there are also some delivery strategies that make nanoparticles smarter and more efficient in drug delivery, and frontiers in these strategies are also summarized in this review. Except these excellent works in newly-produced drug delivery nanoparticles, some points of view and future expectations are made in the end.
Elsevier